Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified fibroblast growth factors for the treatment of ocular disorders

Modified fibroblast growth factors for the treatment of ocular disorders

US Patent 11103553 · Granted Aug 31, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for angiogenic treatment in wound healing2024
Recombinant modified fibroblast growth factors and therapeutic uses thereof2022
Therapeutic angiogenesis for treatment of the spine and other tissues2022
Angiogenic treatment of ischemic heart disease2021
Systems and methods for angiogenic treatment in wound healing2020
Treatment of autoimmune and/or inflammatory disease using novel caveolin modulat2020
Therapeutic angiogenesis for treatment of the spine2015
Inhibitor of vascular endothelial cell growth factor2011
Inhibitor of vascular endothelial cell growth factor2006
DNA molecules encoding vascular endothelial cell growth factor II subunits2005
Human receptor tyrosine kinase, KDR2005
Human receptor tyrosine kinase, KDR2005